Evidence map›Paper›PMID 34439949›Full record

ArticleBiology2021

Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson's Disease.

Amit Sharma, Jens Müller, Karin Schuetze, Verena Rolfes, Rosi Bissinger, Nathalia Rosero, Ashar Ahmad, Bernardo S Franklin, Berndt Zur, Holger Fröhlich and 4 more

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Amit SharmaDepartment of Neurology, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-2216-5389
Jens MüllerInstitute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.
Karin SchuetzeCellTool Gmbh, Am Neuland 1, 82347 Bernried, Germany.
Verena RolfesInstitute of Innate Immunity, University Hospital Bonn, 53127 Bonn, Germany.
Rosi BissingerDepartment of Internal Medicine IV, Eberhard Karl University, 72076 Tuebingen, Germany.
Nathalia RoseroInstitute of Innate Immunity, University Hospital Bonn, 53127 Bonn, Germany.
Ashar AhmadBonn-Aachen International Center for IT (B-IT), University Hospital Bonn, 53115 Bonn, Germany.
Bernardo S FranklinInstitute of Innate Immunity, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0003-2591-9833
Berndt ZurCentral Laboratory of the Rheinland Klinikum Neuss, 41464 Neuss, Germany.
Holger FröhlichBonn-Aachen International Center for IT (B-IT), University Hospital Bonn, 53115 Bonn, Germany.ORCID 0000-0002-5328-1243
Florian LangDepartment of Physiology, Eberhard Karls University, 72076 Tuebingen, Germany.
Johannes OldenburgInstitute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-1585-4100
Bernd PötzschInstitute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, 53127 Bonn, Germany.
Ullrich WüllnerDepartment of Neurology, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-3132-0790
University Hospital Bonn · DEUniversity of Tübingen · DELukaskrankenhaus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common age-related neurodegenerative disease. Accumulating evidence demonstrates that alpha-synuclein (α-Syn), an apparently predominant neuronal protein, is a major contributor to PD pathology. As α-Syn is also highly abundant in blood, particularly in red blood cells (RBCs) and platelets, this in turn raises the question on the function of presumably dysfunctional α-Syn in "peripheral" cells and its putative effect on the other enclosed constituents. Herein, we detected the internal variance in erythrocytes of PD patients by Raman spectroscopy, but no measurable amount of erythrocytic behavioural change (eryptosis) or any haemoglobin variation was noticed. An elevated level of plasmin-antiplasmin complexes (PAP) was observed in the plasma of PD patients, indicating activation of the fibrinolytic system, but platelet activation after thrombin stimulation was not altered. Sex-specific patterns were noticed for blood coagulation factor XIII and factor XII activity in PD patients. Additionally, the alterations in homocysteine levels which have often been observed in PD patients were found to be independent from L-DOPA usage and PAP levels. Furthermore, a selective gene expression analysis identified subsets of genes related to different blood-associated compartments (RBCs, platelets, coagulation-fibrinolysis) also involved in PD-related pathways.

Indexed as

blood coagulationeryptosishaemoglobinhomocysteineL-DOPAParkinson’s diseaseplasmin-antiplasmin complexesplateletsα-Synuclein

Identifiers

PMID34439949
PMCPMC8389253
OpenAlexW3183363095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.